AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

Learn about interactions between Enbrel and other medications, supplements, foods, alcohol, and more. You can also find out ...

Pfizer has received approval from the US FDA for its rheumatoid arthritis (RA) drug, Xeljanz, which is the first approved RA treatment in a new class of medicines known as Janus kinase inhibitors ...

Semaglutide, a weight-loss drug, can reduce knee pain Arthritis patients, in a study, showed improved physicl activity However, weight loss with lifestyle changes is key for sustained health benefits ...

Studies show that kidney involvement in rheumatoid arthritis happens between 20% and 50% of the time. Most commonly, RA can cause inflammation of the kidneys, a condition called glomerulonephritis.

Nov. 5, 2024 — Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and ...

If you take medications to treat rheumatoid arthritis, smoking can interfere with their activity and make them less effective. This includes such foundational medications as methotrexate and newer TNF ...

Some pain relievers can interact with other medications or cause side ... That’s why we’ve put together a list of the best pain relievers for arthritis in the shoulder. These products have ...

A once-weekly 2.4 mg subcutaneous injection of the novel antidiabetic wonder drug was observed to reduce ... over existing antidiabetic modalities. Arthritis is an umbrella term for several ...

Ablynx is looking for new partners to take its rheumatoid arthritis drug vobarilizumab into phase 3 development, after AbbVie turned down an option to license the drug. AbbVie has already paid the ...

Among patients with rheumatoid arthritis, JAK inhibitors were slightly more effective for reducing pain at 3 and 12 months when compared with TNF inhibitors.

Tracking patient response to DMARD therapy has the potential to improve remission, but multiple barriers must be overcome before it’s widely adopted.